The Cooper Companies, Inc. (NASDAQ:COO) Shares Bought by Kayne Anderson Rudnick Investment Management LLC

Kayne Anderson Rudnick Investment Management LLC grew its position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 3.0% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 7,820,590 shares of the medical device company's stock after purchasing an additional 231,155 shares during the period. Cooper Companies makes up about 1.7% of Kayne Anderson Rudnick Investment Management LLC's investment portfolio, making the stock its 12th largest position. Kayne Anderson Rudnick Investment Management LLC owned approximately 3.93% of Cooper Companies worth $682,738,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in COO. Benjamin F. Edwards & Company Inc. increased its stake in shares of Cooper Companies by 248.6% in the first quarter. Benjamin F. Edwards & Company Inc. now owns 244 shares of the medical device company's stock worth $25,000 after buying an additional 174 shares during the last quarter. Innealta Capital LLC bought a new stake in shares of Cooper Companies in the second quarter worth $25,000. Covestor Ltd increased its stake in shares of Cooper Companies by 305.9% in the first quarter. Covestor Ltd now owns 276 shares of the medical device company's stock worth $28,000 after buying an additional 208 shares during the last quarter. Crewe Advisors LLC increased its stake in shares of Cooper Companies by 286.4% in the second quarter. Crewe Advisors LLC now owns 340 shares of the medical device company's stock worth $30,000 after buying an additional 252 shares during the last quarter. Finally, Tortoise Investment Management LLC increased its stake in shares of Cooper Companies by 75.4% in the second quarter. Tortoise Investment Management LLC now owns 393 shares of the medical device company's stock worth $34,000 after buying an additional 169 shares during the last quarter. Hedge funds and other institutional investors own 24.39% of the company's stock.

Insider Buying and Selling

In related news, COO Daniel G. Mcbride sold 114,992 shares of the company's stock in a transaction dated Wednesday, September 4th. The shares were sold at an average price of $105.48, for a total value of $12,129,356.16. Following the completion of the sale, the chief operating officer now owns 44,696 shares of the company's stock, valued at $4,714,534.08. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Cooper Companies news, COO Daniel G. Mcbride sold 114,992 shares of the company's stock in a transaction dated Wednesday, September 4th. The shares were sold at an average price of $105.48, for a total value of $12,129,356.16. Following the completion of the sale, the chief operating officer now directly owns 44,696 shares of the company's stock, valued at approximately $4,714,534.08. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Agostino Ricupati sold 1,601 shares of the company's stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total transaction of $172,956.03. Following the completion of the sale, the chief accounting officer now directly owns 4,818 shares of the company's stock, valued at $520,488.54. The disclosure for this sale can be found here. Insiders sold 256,373 shares of company stock valued at $27,637,427 over the last 90 days. 2.00% of the stock is currently owned by company insiders.

Cooper Companies Stock Performance

Shares of COO traded down $0.61 during midday trading on Friday, hitting $110.49. 1,914,533 shares of the stock traded hands, compared to its average volume of 1,125,396. The Cooper Companies, Inc. has a 1-year low of $75.93 and a 1-year high of $112.38. The firm has a market capitalization of $22.00 billion, a PE ratio of 64.99, a price-to-earnings-growth ratio of 2.60 and a beta of 0.98. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.18 and a current ratio of 1.99. The business's 50 day moving average price is $97.93 and its two-hundred day moving average price is $95.54.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.91 by $0.05. The company had revenue of $1 billion during the quarter, compared to the consensus estimate of $997.30 million. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The company's revenue for the quarter was up 7.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.84 earnings per share. Equities research analysts predict that The Cooper Companies, Inc. will post 3.66 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on COO shares. Morgan Stanley lifted their price target on shares of Cooper Companies from $95.00 to $104.00 and gave the stock an "equal weight" rating in a research note on Tuesday, September 10th. Robert W. Baird boosted their target price on shares of Cooper Companies from $118.00 to $125.00 and gave the company an "outperform" rating in a research note on Thursday, August 29th. Needham & Company LLC reiterated a "hold" rating on shares of Cooper Companies in a research note on Thursday, August 29th. Wells Fargo & Company boosted their target price on shares of Cooper Companies from $110.00 to $115.00 and gave the company an "overweight" rating in a research note on Thursday, August 29th. Finally, Stifel Nicolaus reiterated a "buy" rating and set a $115.00 target price (up previously from $110.00) on shares of Cooper Companies in a research note on Thursday, August 29th. Four analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company's stock. According to MarketBeat.com, Cooper Companies presently has a consensus rating of "Moderate Buy" and a consensus target price of $115.00.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.